(BUD) Anheuser Busch Inbev - Ratings and Ratios
Beer, Spirits, Non-Alcohol
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.03% |
| Yield on Cost 5y | 2.00% |
| Yield CAGR 5y | 11.62% |
| Payout Consistency | 89.8% |
| Payout Ratio | 34.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.0% |
| Value at Risk 5%th | 33.9% |
| Relative Tail Risk | -6.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 6.89 |
| CAGR/Max DD | 0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.561 |
| Beta | 0.248 |
| Beta Downside | 0.158 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| Mean DD | 9.65% |
| Median DD | 8.94% |
Description: BUD Anheuser Busch Inbev September 25, 2025
Anheuser-Busch InBev (NYSE:BUD) is the world’s largest brewer, operating a vertically integrated model that produces, distributes, exports, markets, and sells beer across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. Its portfolio spans roughly 500 brands, anchored by global icons such as Budweiser, Corona Extra, Stella Artois, and Michelob Ultra, while also covering regional favorites (e.g., Brahma, Skol, Jupiler) and an expanding non-beer segment that includes ready-to-drink spirits (Cutwater) and functional beverages (NÜTRL).
From a financial standpoint, AB InBev reported FY 2023 revenue of approximately $58.5 billion, delivering a net income of $5.9 billion and diluted EPS of $5.78. The company generated free cash flow of about $7 billion, but carries a leveraged balance sheet with net debt near $95 billion, yielding a debt-to-EBITDA ratio of roughly 3.5×. Volume growth in mature markets has been flat, while price-realized growth-driven by premiumization and higher-margin product mix-has been the primary earnings engine.
Key economic and sector drivers shaping AB InBev’s outlook include (1) commodity cost volatility, especially barley and aluminum, which directly affect brewhouse margins; (2) shifting consumer preferences toward low-calorie, low-alcohol, and ready-to-drink formats, prompting the company’s $2 billion-plus investment in its non-beer portfolio; and (3) exchange-rate exposure, with a strong U.S. dollar compressing earnings from emerging-market sales that account for roughly 30 % of total volume.
For a deeper, data-driven valuation of BUD, the ValueRay platform offers a granular breakdown of its forward cash-flow assumptions and sensitivity analyses.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (6.10b TTM) > 0 and > 6% of Revenue (6% = 3.52b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -17.18% (prev -49.68%; Δ 32.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 15.20b > Net Income 6.10b (YES >=105%, WARN >=100%) |
| Net Debt (61.00b) to EBITDA (15.54b) ratio: 3.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.79% (target <= -2.0% for YES) |
| Gross Margin 55.91% (prev 43.72%; Δ 12.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.52% (prev 27.08%; Δ 0.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.23 (EBITDA TTM 15.54b / Interest Expense TTM 5.03b) >= 6 (WARN >= 3) |
Altman Z'' 1.49
| (A) -0.05 = (Total Current Assets 23.00b - Total Current Liabilities 33.07b) / Total Assets 206.64b |
| (B) 0.23 = Retained Earnings (Balance) 46.58b / Total Assets 206.64b |
| (C) 0.05 = EBIT TTM 11.23b / Avg Total Assets 212.99b |
| (D) 0.68 = Book Value of Equity 80.67b / Total Liabilities 117.94b |
| Total Rating: 1.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.26
| 1. Piotroski 4.50pt |
| 2. FCF Yield 6.25% |
| 3. FCF Margin 19.90% |
| 4. Debt/Equity 0.79 |
| 5. Debt/Ebitda 3.92 |
| 6. ROIC - WACC (= 0.38)% |
| 7. RoE 7.19% |
| 8. Rev. Trend 30.89% |
| 9. EPS Trend 51.26% |
What is the price of BUD shares?
Over the past week, the price has changed by -1.50%, over one month by -0.25%, over three months by -1.58% and over the past year by +16.58%.
Is BUD a buy, sell or hold?
- Strong Buy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.1 | 25.3% |
| Analysts Target Price | 77.1 | 25.3% |
| ValueRay Target Price | 64 | 4% |
BUD Fundamental Data Overview November 26, 2025
P/E Trailing = 20.7309
P/E Forward = 14.9477
P/S = 2.0767
P/B = 1.5103
P/EG = 1.2527
Beta = 0.671
Revenue TTM = 58.61b USD
EBIT TTM = 11.23b USD
EBITDA TTM = 15.54b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 186.50b USD (121.70b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 2.23 (Ebit TTM 11.23b / Interest Expense TTM 5.03b)
FCF Yield = 6.25% (FCF TTM 11.66b / Enterprise Value 186.50b)
FCF Margin = 19.90% (FCF TTM 11.66b / Revenue TTM 58.61b)
Net Margin = 10.41% (Net Income TTM 6.10b / Revenue TTM 58.61b)
Gross Margin = 55.91% ((Revenue TTM 58.61b - Cost of Revenue TTM 25.84b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.90 (Enterprise Value 186.50b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 7.62b (EBIT 11.23b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 3.92 (Net Debt 61.00b / EBITDA 15.54b)
Debt / FCF = 5.23 (Net Debt 61.00b / FCF TTM 11.66b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 6.10b / Total Assets 206.64b)
RoE = 7.19% (Net Income TTM 6.10b / Total Stockholder Equity 84.76b)
RoCE = 7.31% (EBIT 11.23b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 5.05% (NOPAT 7.62b / Invested Capital 151.01b)
WACC = 4.67% (E(121.70b)/V(193.87b) * Re(6.93%) + D(72.17b)/V(193.87b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 78.17% ; FCFE base≈11.27b ; Y1≈11.17b ; Y5≈11.66b
Fair Price DCF = 119.5 (DCF Value 206.59b / Shares Outstanding 1.73b; 5y FCF grow -1.57% → 3.0% )
EPS Correlation: 51.26 | EPS CAGR: 2.57% | SUE: 0.41 | # QB: 0
Revenue Correlation: 30.89 | Revenue CAGR: 1.72% | SUE: -0.10 | # QB: 0
Additional Sources for BUD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle